Diercks Deborah B, Kontos Michael C, Chen Anita Y, Pollack Charles V, Wiviott Stephen D, Rumsfeld John S, Magid David J, Gibler W Brian, Cannon Christopher P, Peterson Eric D, Roe Matthew T
Department of Emergency Medicine, University of California, Davis Medical Center, Sacramento, CA 95661, USA.
J Am Coll Cardiol. 2009 Jan 13;53(2):161-6. doi: 10.1016/j.jacc.2008.09.030.
This study sought to determine the association of pre-hospital electrocardiograms (ECGs) and the timing of reperfusion therapy for patients with ST-segment elevation myocardial infarction (STEMI).
Pre-hospital ECGs have been recommended in the management of patients with chest pain transported by emergency medical services (EMS).
We evaluated patients with STEMI from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) registry who were transported by EMS from January 1, 2007, through December 31, 2007. Patients were stratified by the use of pre-hospital ECGs, and timing of reperfusion therapy was compared between the 2 groups.
A total of 7,098 of 12,097 patients (58.7%) utilized EMS, and 1,941 of these 7,098 EMS transport patients (27.4%) received a pre-hospital ECG. Among the EMS transport population, primary percutaneous coronary intervention was performed in 92.1% of patients with a pre-hospital ECG versus 86.3% with an in-hospital ECG, whereas fibrinolytic therapy was used in 4.6% versus 4.2% of patients. Median door-to-needle times for patients receiving fibrinolytic therapy (19 min vs. 29 min, p = 0.003) and median door-to-balloon times for patients undergoing primary percutaneous coronary intervention (61 min vs. 75 min, p < 0.0001) were significantly shorter for patients with a pre-hospital ECG. A suggestive trend for a lower risk of in-hospital mortality was observed with pre-hospital ECG use (adjusted odds ratio: 0.80, 95% confidence interval: 0.63 to 1.01).
Only one-quarter of these patients transported by EMS receive a pre-hospital ECG. The use of a pre-hospital ECG was associated with a greater use of reperfusion therapy, faster reperfusion times, and a suggested trend for a lower risk of mortality.
本研究旨在确定ST段抬高型心肌梗死(STEMI)患者的院前心电图(ECG)与再灌注治疗时机之间的关联。
对于由紧急医疗服务(EMS)转运的胸痛患者,推荐进行院前心电图检查。
我们评估了2007年1月1日至2007年12月31日期间由EMS转运的来自国家心血管数据注册库(NCDR)急性冠状动脉治疗和干预结果网络(ACTION)注册研究中的STEMI患者。根据是否使用院前心电图对患者进行分层,并比较两组之间再灌注治疗的时机。
在12097例患者中,共有7098例(58.7%)使用了EMS,在这7098例EMS转运患者中,有1941例(27.4%)接受了院前心电图检查。在EMS转运人群中,接受院前心电图检查的患者中有92.1%接受了直接经皮冠状动脉介入治疗,而接受院内心电图检查的患者中这一比例为86.3%;接受纤溶治疗的患者比例分别为4.6%和4.2%。接受纤溶治疗的患者的中位门到针时间(19分钟对29分钟,p = 0.003)以及接受直接经皮冠状动脉介入治疗的患者的中位门到球囊时间(61分钟对75分钟,p < 0.0001),对于接受院前心电图检查的患者明显更短。观察到使用院前心电图有降低院内死亡风险的提示性趋势(调整后的优势比:0.80,95%置信区间:0.63至1.01)。
这些由EMS转运的患者中只有四分之一接受了院前心电图检查。院前心电图的使用与更多地使用再灌注治疗、更快的再灌注时间以及降低死亡风险的提示性趋势相关。